Anterix (ATEX) Non-Current Deffered Revenue (2016 - 2025)
Historic Non-Current Deffered Revenue for Anterix (ATEX) over the last 12 years, with Q4 2025 value amounting to $124.7 million.
- Anterix's Non-Current Deffered Revenue rose 385.52% to $124.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $124.7 million, marking a year-over-year increase of 385.52%. This contributed to the annual value of $118.6 million for FY2025, which is 244.94% up from last year.
- Latest data reveals that Anterix reported Non-Current Deffered Revenue of $124.7 million as of Q4 2025, which was up 385.52% from $123.5 million recorded in Q3 2025.
- Anterix's 5-year Non-Current Deffered Revenue high stood at $124.7 million for Q4 2025, and its period low was $2.1 million during Q2 2021.
- Over the past 5 years, Anterix's median Non-Current Deffered Revenue value was $66.8 million (recorded in 2022), while the average stood at $76.6 million.
- Per our database at Business Quant, Anterix's Non-Current Deffered Revenue tumbled by 1909.06% in 2021 and then skyrocketed by 242669.57% in 2022.
- Quarter analysis of 5 years shows Anterix's Non-Current Deffered Revenue stood at $53.5 million in 2021, then rose by 9.67% to $58.7 million in 2022, then skyrocketed by 71.85% to $100.9 million in 2023, then increased by 19.03% to $120.1 million in 2024, then rose by 3.86% to $124.7 million in 2025.
- Its last three reported values are $124.7 million in Q4 2025, $123.5 million for Q3 2025, and $121.9 million during Q2 2025.